Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06532370 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Queen's Medical Center to Queen's Medical Center Show 7 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Dec 30, 2026 to Sep 30, 2026
    • Enrollment target: estimated 40 to confirmed 39
    • Eligibility criteria expanded, about 16 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Publications: details revised at 4 of 4 entries
  2. Primary and study completion pushed from Dec 30, 2025 to Dec 30, 2026
    • Enrollment target: 20 to 40
    • Trial status: Completed to Recruiting
    • Site details revised
    v7
  3. Trial status: Recruiting to Completed
    • Primary and study completion dates changed from estimate of Sep 30, 2025 to Dec 30, 2025
    • Site details revised
    v6
  4. Trial status: Not Yet Recruiting to Recruitingv5 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Jun 30, 2025 to Sep 30, 2025
    • Study completion date: Jul 30, 2025 to Sep 30, 2025
    • Start date changed from estimate of Oct 15, 2024 to Oct 10, 2024
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Oct 1, 2025 to Jun 30, 2025
    • Study completion date: Oct 1, 2025 to Jul 30, 2025
    • Start date: Oct 1, 2024 to Oct 15, 2024
    v3
  2. Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Collaborators expanded, about 7 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to use contingency management (CM) as an intervention tool to address methamphetamine use. The main objectives are to: * Gather effectiveness data on a pilot a CM program for participants in Hawaii who use methamphetamine following hospitalization due to traumatic injury * To assess participant perspectives on engaging with a CM program based at a Level 1 Trauma Center. Researches will assess both patient-reported and biologically-confirmed medium-term program effectiveness and conduct qualitative interviews with participants post-program. Participants will: * Visit a follow-up clinic up to three times per week to complete urinalysis following discharge from the trauma unit * Complete Treatment Effectiveness Assessments at 6 and 12-weeks * Engage in a qualitative interview at the end of the CM program
Trial Details
NCT Number NCT06532370
Lead Sponsor Queen's Medical Center
Collaborators: National Institute of General Medical Sciences (NIGMS)
Conditions
(from sponsor)		 Contingency Managment, Methamphetamine Use Disorder
Enrollment 39 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov